Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Xbrane Biopharma AB (publ) | 26,250 | net | 14 Mar 2024 | tx 10+28,779−2,529 |
| Xintela AB | 15,000 | net | 31 May 2019 | tx 1+15,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Mar 2024 | PURCHASE | Xbrane Biopharma AB (publ) | 15,000 | 11.50 SEK | first after silence |
| 18 Dec 2020 | PURCHASE | Xbrane Biopharma AB (publ) | 2,253 | 72.76 SEK | |
| 09 Dec 2020 | PURCHASE | Xbrane Biopharma AB (publ) | 2,529 | 69.20 SEK | first after silence |
| 09 Dec 2020 | SALE | Xbrane Biopharma AB (publ) | 2,529 | 69.20 SEK | |
| 28 Jun 2019 | PURCHASE | Xbrane Biopharma AB (publ) | 2,247 | 33.50 SEK | |
| 31 May 2019 | PURCHASE | Xintela AB | 15,000 | 4.80 SEK | |
| 03 Apr 2019 | PURCHASE | Xbrane Biopharma AB (publ) | 540 | 39.30 SEK | |
| 02 Apr 2019 | PURCHASE | Xbrane Biopharma AB (publ) | 117 | 30.00 SEK | |
| 20 Mar 2019 | PURCHASE | Xbrane Biopharma AB (publ) | 2,343 | 30.00 SEK | |
| 06 Apr 2018 | PURCHASE | Xbrane Biopharma AB (publ) | 2,250 | 5.88 SEK | |
| 06 Apr 2018 | PURCHASE | Xbrane Biopharma AB (publ) | 1,500 | 61.04 SEK |
2 purchases reported after at least 12 months of silence — most recent on 14 Mar 2024.